News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Daily News Tricky Population of Patients With A-fib Undergoing PCI Tackled in New Consensus Document Todd Neale November 29, 2016
News Conference News AHA 2016 Rivaroxaban-Based Double or Triple Therapy Cuts Bleeding in Patients With A-fib Undergoing PCI: PIONEER AF-PCI Todd Neale November 14, 2016
News Daily News Oral Anticoagulation Use Common in PCI Patients, With Triple Therapy the Norm at Discharge Todd Neale October 18, 2016
News Daily News Bivalirudin? Heparin? Physicians Are Divided Over Antithrombotic Choices for PCI in STEMI, Survey Shows Yael L. Maxwell September 15, 2016
News Daily News Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI Michael O'Riordan August 24, 2016
News Daily News Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected? Yael L. Maxwell July 27, 2016
News Conference News EuroPCR 2016 Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS Michael O'Riordan May 17, 2016
News Conference News SCAI 2016 Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women L.A. McKeown May 11, 2016
News Conference News SCAI 2016 Bleeding Calculator Use Linked to Dramatic Decrease in Post-PCI Bleeding L.A. McKeown May 05, 2016
News Daily News Nuevos Roles de las Clínicas Especializadas en Anticoagulación en una Era de Opciones Sin Warfarina Todd Neale March 01, 2016
News Daily News New Roles for Anticoagulation Clinics in an Era of Non-Warfarin Options Todd Neale March 01, 2016
News Industry News Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference February 22, 2016
News Daily News Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond December 23, 2015
News Daily News Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI Yael L. Maxwell December 22, 2015
News Daily News Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines Yael L. Maxwell December 14, 2015
News Conference News AHA 2015 Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants Yael L. Maxwell November 10, 2015
News Industry News Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients October 15, 2015
News Conference News TCT 2015 BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR Yael L. Maxwell October 15, 2015